Oncology Clinical Trials in Pittsburgh, PA

As of June 2026, 298 paid clinical trials are recruiting for Oncology in Pittsburgh, Pennsylvania. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

298 clinical trials for Oncology

·Clear filters·↓ Download CSV

Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE

for Cancer

2 locations incl. Pittsburgh

Sponsor: University of Pittsburgh

Sex: All·Age: 21 - 100·Accepts healthy volunteers

Code: NCT05601206·Not Yet Recruiting

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

for Burkitt Lymphoma

Drug: Pidnarulex

4 locations incl. Irvine

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT07069699·Phase 1, Phase 2·Recruiting

Apply to this trial

Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer

for Ovarian Cancer

1 location in Pittsburgh

Sponsor: Kalinski, Pawel, MD, PhD

Sex: Female·Age: 18+

Code: NCT07634094·Phase 2·Not Yet Recruiting

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

for Locally Advanced Lung Non-Small Cell Carcinoma

Drug: Sotorasib

9 locations incl. Sacramento

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT07012031·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

for Acute Myeloid Leukemia Post Cytotoxic Therapy

5 locations incl. Minneapolis

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: Up to 21

Code: NCT07012044·Phase 1·Recruiting

Apply to this trial

Investigating Real-Time Immunotherapy Symptoms Study

for Cancer

1 location in Pittsburgh

Sponsor: University of Pittsburgh

Sex: All·Age: 18+

Code: NCT07280715·Not Yet Recruiting

VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations

for Brain Cancer

Drug: Vorasidenib

1 location in Pittsburgh

Sponsor: Megan Mantica

Sex: All·Age: 18+

Code: NCT07629089·Phase 1·Not Yet Recruiting

Bevonescein for Improved Intraoperative Nerve Visualization to Improve Voice Outcomes in Thyroidectomy Patients

for Head and Neck Disorder

1 location in Pittsburgh

Sponsor: Matthew Spector

Sex: All·Age: 18+

Code: NCT07631650·Phase 2·Not Yet Recruiting

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

for Acute Lymphocytic Leukemia (ALL)

1 location in Pittsburgh

Sponsor: Sawa Ito, MD

Sex: All·Age: 18+

Code: NCT07565220·Phase 1·Not Yet Recruiting

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

for Head and Neck Squamous Cell Carcinoma

Drug: Cemiplimab

6 locations incl. Irvine

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06980038·Phase 2·Recruiting

Apply to this trial

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

for Glioblastoma (GBM)

12 locations incl. Springdale

Sponsor: Black Diamond Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07326566·Phase 2·Recruiting

Apply to this trial

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

for Metastatic Castration-resistant Prostate Cancer

24 locations incl. Dothan

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT07611110·Phase 3·Recruiting

Apply to this trial

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

for Skin Cancer

2 locations incl. Pittsburgh

Sponsor: Marissa Lobl

Sex: All·Age: 18+

Code: NCT07286318·EARLY_Phase 1·Recruiting

Apply to this trial

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for Solid Tumors

Drug: INCB161734

68 locations incl. Birmingham

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT07522073·Phase 3·Recruiting

Apply to this trial

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

for Breast Neoplasms

39 locations incl. Birmingham

Sponsor: Natera, Inc.

Sex: All·Age: 18+

Code: NCT07214532·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

for Non-Small Cell Lung Cancer (NSCLC)

Drug: Pumitamig

40 locations incl. Daphne

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07361510·Phase 3·Recruiting

Apply to this trial

Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar

for Colorectal Cancer

4 locations incl. Louisville

Sponsor: Exero Medical Ltd.

Sex: All·Age: 21+

Code: NCT07337590·Recruiting

Apply to this trial

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for Gastric Cancer

Drug: Sonesitatug vedotin

77 locations incl. Phoenix

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07431281·Phase 3·Recruiting

Apply to this trial

Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application

for Cancer

1 location in Pittsburgh

Sponsor: University of Pittsburgh

Sex: All·Age: 18+

Code: NCT07218874·Recruiting

Apply to this trial

ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC

for Triple Negative Breast Cancer

1 location in Pittsburgh

Sponsor: University of Pittsburgh

Sex: Female·Age: 18+

Code: NCT07332975·Recruiting

Apply to this trial

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

for Colorectal Cancer

Drug: Atezolizumab

6 locations incl. Aurora

Sponsor: Kahr Bio Australia Pty Ltd

Sex: All·Age: 18+

Code: NCT07235293·Phase 2·Recruiting

Apply to this trial

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for Large B-cell Lymphoma

38 locations incl. Gilbert

Sponsor: Lyell Immunopharma, Inc.

Sex: All·Age: 18+

Code: NCT07188558·Phase 3·Recruiting

Apply to this trial

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

for Non-small Cell Lung Cancer

70 locations incl. Phoenix

Sponsor: Canadian Cancer Trials Group

Sex: All·Age: 18+

Code: NCT06686771·Phase 3·Recruiting

Apply to this trial

for Metastatic Castration-resistant Prostate Cancer

29 locations incl. Goodyear

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT07213674·Phase 3·Recruiting

Apply to this trial

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

for Non-Small Cell Lung Cancer

28 locations incl. Irvine

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07100080·Phase 2, Phase 3·Recruiting

Apply to this trial

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

for Renal Cell Carcinoma

1 location in Pittsburgh

Sponsor: Diwakar Davar

Sex: All·Age: 18+

Code: NCT07223424·Phase 2·Recruiting

for Prostate Cancer

1 location in Pittsburgh

Sponsor: University of Pittsburgh

Sex: Male·Age: 18+

Code: NCT07222436·Recruiting

Apply to this trial

9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

for Pancreatic Adenocarcinoma

Drug: Retifanlimab

1 location in Pittsburgh

Sponsor: Anwaar Saeed

Sex: All·Age: 18+

Code: NCT06896188·Phase 1·Recruiting

Apply to this trial

Use of Wearables Following Cystectomy- Part II

for Bladder Cancer

1 location in Pittsburgh

Sponsor: University of Pittsburgh

Sex: All·Age: 18+

Code: NCT07148765·Enrolling By Invitation

Pittsburgh has approximately 1,330 recruiting research studies across a wide range of therapeutic areas. Pennsylvania hosts UPenn's Perelman School of Medicine and Children's Hospital of Philadelphia — pioneers in CAR-T cell therapy — alongside UPMC, Thomas Jefferson University, and Penn State Hershey.

Top Research Study Locations in Pittsburgh

Researchers run research studies in Pittsburgh, PA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.

Site	Specializes in	Active trials
University of Pittsburgh	Stroke, Traumatic Brain Injury, Dementia	164
University of Pittsburgh Medical Center	Chronic Pancreatitis, Cystic Fibrosis, Advanced Solid Tumor	147
UPMC Hillman Cancer Center	Melanoma, Glioma, Hepatocellular Carcinoma	87
University of Pittsburgh Cancer Institute (UPCI)	Acute Myeloid Leukemia, Metastatic Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8	87
Allegheny General Hospital	Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Cancer	67
Children's Hospital of Pittsburgh of UPMC	B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, Neuroblastoma	61
UPMC Children's Hospital of Pittsburgh	Biliary Atresia, Fabry Disease, Congenital Bone Marrow Failure Syndromes	55
UPMC-Passavant Hospital	Recurrent Endometrial Carcinoma, Anatomic Stage II Breast Cancer AJCC v8, Prostate Adenocarcinoma	39
Allegheny Health Network	Atrial Fibrillation, Bladder Cancer, Brain Tumor	35
UPMC-Saint Clair Hospital Cancer Center	Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Head and Neck Squamous Cell Carcinoma	30
UPMC-Saint Margaret	Prostate Adenocarcinoma, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8	27
West Penn Hospital	Breast Cancer, Large B-cell Lymphoma, Stage IV Colorectal Cancer AJCC v8	27
UPMC-Magee Womens Hospital	Breast Cancer, Recurrent Endometrial Carcinoma, Anatomic Stage II Breast Cancer AJCC v8	26
UPMC-Shadyside Hospital	Stage IV Renal Cell Cancer AJCC v8, Breast Cancer, Head and Neck Squamous Cell Carcinoma	26
UPMC	Focal Epilepsy, Ovarian Cancer, ASD - Atrial Septal Defect	23
UPMC Presbyterian	Acute Kidney Injuries, Aneurysm of Aorta, Thoracic, Aneurysmal Disease	20
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA	Cardiovascular Diseases, Stroke, Acute Kidney Injury	20
Children's Hospital of Pittsburgh	Diabetes Mellitus, Type 2, Hyperglycemia, Physical Inactivity	19
UPMC Presbyterian Hospital	Abdominal Surgery, Acute Ischemic Stroke, Acute Myocardial Infarction	18
UPMC Magee-Womens Hospital	ADHD, Behavioral Intervention, Breast Cancer	9
UPMC Shadyside Hospital	Opioid Use Disorder, Abdominal Surgery, Anxiety Preoperative	9
University of Pittsburgh School of Medicine	Adolescents, Anorexia Nervosa, Bipolar Disorder (BD)	9
AHN West Penn Hospital	Malignant Mesothelioma, Malignant Pleural Effusion, Metastasis to Pleura	8
University of Pittsburgh Medical Center (UPMC)	ALS, ALS (Amyotrophic Lateral Sclerosis), ALS - Amyotrophic Lateral Sclerosis	8
UPMC-Presbyterian Hospital	Metastatic Malignant Neoplasm in the Brain, Stage IV Lung Cancer AJCC v8, Adenocarcinoma of the Colon	7

Active & Upcoming Studies in Pittsburgh (2026)

Recruiting trials in Pittsburgh grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.

Pediatric (17 active studies)

HIV / STI (10 active studies)

mHealth Service Linkage for Young Adults Impacted by the Criminal Legal System · University of Pittsburgh
Small Trial of Alendronate Impact on the Reservoir of HIV · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)

Vaccines (9 active studies)

A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine · Phase 3 · Pfizer
A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure · Phase 2 · Tarsus Pharmaceuticals, Inc.

Eye & vision (4 active studies)

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD · Phase 3 · AbbVie
The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease · Rinsada

Common conditions studied in Pittsburgh

Breast Cancer (26 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Cancer (20 active studies). Recruiting Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Melanoma (19 active studies). Melanoma trials test immune checkpoint inhibitors, adoptive cell therapies, and BRAF/MEK targeted combinations in both early and metastatic disease.
Stroke (18 active studies). Stroke trials test acute reperfusion strategies, neuroprotective agents, and rehabilitation technologies to improve recovery.
Endometrial Cancer (14 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Ovarian Cancer (14 active studies). Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease.

Leading research sponsors in Pittsburgh

University of Pittsburgh
National Cancer Institute (NCI)
AstraZeneca
Children's Oncology Group
VA Office of Research and Development

Local regulations and guidelines

Clinical trials in Pennsylvania are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Pennsylvania research additionally follows state public health department oversight and any applicable state privacy statutes.

Compensation & what to expect

How payment typically works: Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
Healthy volunteers: Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Pittsburgh. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
What's included beyond payment: Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
Travel and time: Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
Asking about compensation: Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.

How to find a clinical trial in Pittsburgh

Hipa.ai aggregates every recruiting study in Pittsburgh from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.

Frequently asked questions

How many paid clinical trials are currently recruiting in Pittsburgh?

There are approximately 1,330 recruiting clinical trials in Pittsburgh, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Pittsburgh pay participants?

Most recruiting trials in Pittsburgh compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Pittsburgh?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Pittsburgh?

The most common conditions under active study in Pittsburgh include Breast Cancer (26), Cancer (20), Melanoma (19), Stroke (18), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Pittsburgh?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Pittsburgh on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Pittsburgh?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Pittsburgh?

Recruiting research sites in Pittsburgh include University of Pittsburgh, University of Pittsburgh Medical Center, UPMC Hillman Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Pittsburgh right now?

The largest active categories in Pittsburgh are Cancer & tumors (440), Neurology & pain (87), Cardiovascular (74). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Other cities in Pennsylvania

Philadelphia, PA(2,086)Hershey, PA(293)Danville, PA(142)Allentown, PA(139)Bethlehem, PA(109)York, PA(108)Erie, PA(93)Wilkes-Barre, PA(85)Lancaster, PA(80)Harrisburg, PA(70)Monroeville, PA(68)Wynnewood, PA(61)Lewisburg, PA(55)Hazleton, PA(53)Willow Grove, PA(48)East Stroudsburg, PA(46)Mechanicsburg, PA(45)West Reading, PA(45)Chadds Ford, PA(44)Scranton, PA(41)Greensburg, PA(40)Media, PA(37)Sayre, PA(37)Duncansville, PA(35)Chambersburg, PA(33)Camp Hill, PA(31)Uniontown, PA(31)University Park, PA(31)Dickson City, PA(30)Easton, PA(30)Paoli, PA(29)Pottsville, PA(29)Bryn Mawr, PA(28)DuBois, PA(28)Gettysburg, PA(28)Beaver, PA(27)Lebanon, PA(27)Bala-Cynwyd, PA(26)Ephrata, PA(26)West Chester, PA(26)Abington, PA(25)Farrell, PA(25)Wexford, PA(25)State College, PA(24)New Castle, PA(23)Washington, PA(23)Wyomissing, PA(23)Altoona, PA(22)Jefferson Hills, PA(21)Johnstown, PA(21)Seneca, PA(21)Horsham, PA(20)Indiana, PA(20)Natrona Heights, PA(20)Plymouth Meeting, PA(20)Cranberry Township, PA(19)Exton, PA(18)Butler, PA(17)Carlisle, PA(16)Pottstown, PA(16)

Related healthcare resources in Pennsylvania

Latest Pittsburgh, PA clinical trials research report

Trials by condition in Pittsburgh

Breast Cancer· 26 Melanoma· 19 Stroke· 18 Endometrial Cancer· 14 Ovarian Cancer· 14 Prostate Cancer· 13

Conditions in Oncology (Pittsburgh, PA)

Solid tumor· 45 Non-small cell lung cancer (NSCLC)· 43 Breast cancer· 33 Cancer (any)· 33 Melanoma· 24 Head and neck cancer· 19 Prostate cancer· 17 Colorectal cancer· 16 Ovarian cancer· 16 Pancreatic cancer· 14 Endometrial cancer· 14 Esophageal cancer· 13 Liver cancer· 12 Acute myeloid leukemia (AML)· 11 Gastric cancer· 10 Kidney cancer· 9 Multiple myeloma· 9 Myelodysplastic syndromes (MDS)· 9 Diffuse large B-cell lymphoma (DLBCL)· 9 Triple-negative breast cancer· 7 Fallopian tube cancer· 7 Skin cancer· 7 Metastatic breast cancer· 6 Lung cancer· 6 Metastatic prostate cancer· 6 Glioblastoma· 6 Leukemia (other)· 6 Biliary tract cancer· 5 Glioma· 5 Brain cancer· 5 Non-Hodgkin lymphoma· 5 Hematologic malignancy· 5 Bladder cancer· 4 Cervical cancer· 4 Chronic lymphocytic leukemia (CLL)· 4 Follicular lymphoma· 4 Sarcoma· 4 Mesothelioma· 4 HER2-positive breast cancer· 3 Small cell lung cancer· 3 Acute lymphoblastic leukemia· 3 Myeloproliferative neoplasm· 3 Small lymphocytic lymphoma· 3 Neuroblastoma· 3 HER2-negative breast cancer· 2 Gastroesophageal junction cancer· 2 Myelofibrosis· 2 Mantle cell lymphoma· 2 Metastatic colorectal cancer· 1 Colon cancer· 1 Rectal cancer· 1 Gastrointestinal cancer· 1 Uterine cancer· 1 Gynecologic cancer· 1 Hodgkin lymphoma· 1 Marginal zone lymphoma· 1 Burkitt lymphoma· 1 Thyroid cancer· 1 Soft tissue sarcoma· 1 Osteosarcoma· 1 Neuroendocrine tumors· 1

Oncology Clinical Trials in Pittsburgh, PA

298 clinical trials for Oncology

About research studies in Pittsburgh

Top Research Study Locations in Pittsburgh

Active & Upcoming Studies in Pittsburgh (2026)

Cancer & tumors (440 active studies)

Neurology & pain (87 active studies)

Cardiovascular (74 active studies)

Mental health & behavior (39 active studies)

Diabetes & metabolic (38 active studies)

Pediatric (17 active studies)

HIV / STI (10 active studies)

Vaccines (9 active studies)

Eye & vision (4 active studies)

Common conditions studied in Pittsburgh

Leading research sponsors in Pittsburgh

Local regulations and guidelines

Compensation & what to expect

How to find a clinical trial in Pittsburgh

Frequently asked questions

How many paid clinical trials are currently recruiting in Pittsburgh?

Do clinical trials in Pittsburgh pay participants?

Who can participate in a clinical trial in Pittsburgh?

What conditions are most commonly studied in Pittsburgh?

Are there clinical trials for healthy volunteers in Pittsburgh?

How do I enroll in a clinical trial in Pittsburgh?

Where can I take part in paid clinical trials in Pittsburgh?

What kinds of studies are recruiting in Pittsburgh right now?

Browse more clinical trials

Other cities in Pennsylvania

Related healthcare resources in Pennsylvania

Trials by condition in Pittsburgh

Conditions in Oncology (Pittsburgh, PA)